Study of DF6215 in Patients With Advanced Solid Tumors
Dragonfly Therapeutics
Dragonfly Therapeutics
ViroMissile, Inc.
Tizona Therapeutics, Inc
Dana-Farber Cancer Institute
USWM, LLC (dba US WorldMeds)
IDEAYA Biosciences
SN BioScience
Novartis
TScan Therapeutics, Inc.
Bolt Biotherapeutics, Inc.
Actym Therapeutics, Inc.
Exelixis
Bicara Therapeutics
Thomas Jefferson University
Thomas Jefferson University
Revolution Medicines, Inc.
Checkpoint Therapeutics, Inc.
Carisma Therapeutics Inc
Acepodia Biotech, Inc.
The Affiliated Hospital of Qingdao University
Xencor, Inc.
Pfizer
Corregene Biotechnology Co., Ltd
Pfizer
Celldex Therapeutics
STCube, Inc.
Adaptimmune
Emory University
Fate Therapeutics
Fate Therapeutics
Prelude Therapeutics
Quadriga Biosciences, Inc.
Rubius Therapeutics
Xencor, Inc.
Ludwig Institute for Cancer Research
Revolution Medicines, Inc.
Imperial College London
Silverback Therapeutics
Corregene Biotechnology Co., Ltd
Pfizer
AbbVie
Incyte Corporation
Five Prime Therapeutics, Inc.
Weill Medical College of Cornell University
Mie University
Canadian Cancer Trials Group
Tocagen Inc.
Ipsen
Critical Outcome Technologies Inc.
Inovio Pharmaceuticals